Kenneth Wright
Concepts (379)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 85 | 2026 | 514 | 13.100 |
Why?
| | Sleep | 82 | 2026 | 901 | 9.970 |
Why?
| | Sleep Deprivation | 41 | 2025 | 206 | 9.110 |
Why?
| | Melatonin | 46 | 2025 | 163 | 5.660 |
Why?
| | Wakefulness | 30 | 2023 | 169 | 4.100 |
Why?
| | Sleep Disorders, Circadian Rhythm | 15 | 2025 | 52 | 3.490 |
Why?
| | Circadian Clocks | 14 | 2022 | 59 | 3.220 |
Why?
| | Light | 21 | 2025 | 411 | 2.020 |
Why?
| | Work Schedule Tolerance | 9 | 2021 | 51 | 1.810 |
Why?
| | Energy Metabolism | 11 | 2025 | 935 | 1.760 |
Why?
| | Photoperiod | 11 | 2022 | 55 | 1.710 |
Why?
| | Cognition | 13 | 2022 | 1266 | 1.650 |
Why?
| | Attention | 12 | 2021 | 457 | 1.540 |
Why?
| | Body Temperature | 13 | 2022 | 229 | 1.450 |
Why?
| | Eating | 9 | 2023 | 389 | 1.400 |
Why?
| | Lighting | 6 | 2022 | 30 | 1.400 |
Why?
| | Psychomotor Performance | 11 | 2021 | 328 | 1.380 |
Why?
| | Weight Gain | 6 | 2022 | 556 | 1.370 |
Why?
| | Caffeine | 6 | 2015 | 74 | 1.330 |
Why?
| | Energy Intake | 8 | 2023 | 499 | 1.100 |
Why?
| | Sleep Stages | 6 | 2016 | 75 | 1.080 |
Why?
| | Insulin Resistance | 7 | 2026 | 1241 | 0.960 |
Why?
| | Adult | 72 | 2026 | 40449 | 0.950 |
Why?
| | Reaction Time | 6 | 2017 | 438 | 0.920 |
Why?
| | Humans | 139 | 2026 | 144759 | 0.890 |
Why?
| | Athletic Performance | 1 | 2026 | 76 | 0.890 |
Why?
| | Sunlight | 2 | 2017 | 78 | 0.860 |
Why?
| | Hypnotics and Sedatives | 5 | 2014 | 216 | 0.850 |
Why?
| | Actigraphy | 13 | 2026 | 145 | 0.830 |
Why?
| | Hydrocortisone | 5 | 2019 | 304 | 0.820 |
Why?
| | Male | 94 | 2026 | 72315 | 0.810 |
Why?
| | Sleep Wake Disorders | 6 | 2024 | 301 | 0.800 |
Why?
| | Time Factors | 32 | 2026 | 7173 | 0.790 |
Why?
| | Chronobiology Disorders | 5 | 2020 | 16 | 0.780 |
Why?
| | Obesity | 11 | 2026 | 3077 | 0.770 |
Why?
| | Saliva | 10 | 2025 | 249 | 0.720 |
Why?
| | Biological Clocks | 8 | 2025 | 49 | 0.720 |
Why?
| | Dietary Supplements | 1 | 2026 | 576 | 0.720 |
Why?
| | Depressive Disorder | 1 | 2025 | 387 | 0.690 |
Why?
| | Homeostasis | 5 | 2023 | 640 | 0.680 |
Why?
| | Electroencephalography | 7 | 2021 | 532 | 0.680 |
Why?
| | Sleep Initiation and Maintenance Disorders | 7 | 2024 | 194 | 0.670 |
Why?
| | Young Adult | 30 | 2025 | 14105 | 0.670 |
Why?
| | Female | 82 | 2026 | 78271 | 0.670 |
Why?
| | Photic Stimulation | 7 | 2015 | 264 | 0.660 |
Why?
| | Depression | 4 | 2025 | 1558 | 0.630 |
Why?
| | Communicable Disease Control | 1 | 2020 | 86 | 0.610 |
Why?
| | Individuality | 4 | 2019 | 152 | 0.610 |
Why?
| | Analysis of Variance | 9 | 2015 | 1306 | 0.580 |
Why?
| | Metabolic Diseases | 2 | 2017 | 114 | 0.570 |
Why?
| | Pyridines | 3 | 2014 | 605 | 0.570 |
Why?
| | Students | 4 | 2023 | 663 | 0.520 |
Why?
| | Vision, Ocular | 1 | 2017 | 47 | 0.500 |
Why?
| | Shift Work Schedule | 4 | 2024 | 10 | 0.500 |
Why?
| | Double-Blind Method | 11 | 2015 | 2029 | 0.490 |
Why?
| | Stress, Physiological | 4 | 2015 | 453 | 0.490 |
Why?
| | Metabolomics | 3 | 2023 | 727 | 0.490 |
Why?
| | Accidents, Traffic | 3 | 2020 | 190 | 0.480 |
Why?
| | Gastrointestinal Microbiome | 5 | 2026 | 771 | 0.480 |
Why?
| | Polysomnography | 10 | 2020 | 235 | 0.470 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.440 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.440 |
Why?
| | Disorders of Excessive Somnolence | 5 | 2012 | 38 | 0.430 |
Why?
| | Medical Errors | 3 | 2021 | 118 | 0.430 |
Why?
| | Surveys and Questionnaires | 11 | 2025 | 6048 | 0.420 |
Why?
| | Indenes | 2 | 2010 | 6 | 0.400 |
Why?
| | Diseases in Twins | 3 | 2020 | 115 | 0.400 |
Why?
| | Adolescent | 26 | 2026 | 22428 | 0.390 |
Why?
| | Proteome | 1 | 2018 | 518 | 0.390 |
Why?
| | Interleukin-10 | 1 | 2015 | 309 | 0.380 |
Why?
| | Prebiotics | 2 | 2024 | 28 | 0.370 |
Why?
| | Visual Perception | 2 | 2015 | 183 | 0.370 |
Why?
| | Overweight | 3 | 2026 | 609 | 0.370 |
Why?
| | Bone Remodeling | 3 | 2022 | 71 | 0.370 |
Why?
| | Biomarkers | 10 | 2024 | 4271 | 0.360 |
Why?
| | Diabetes Mellitus | 2 | 2023 | 1098 | 0.350 |
Why?
| | Receptor, Melatonin, MT1 | 2 | 2015 | 6 | 0.350 |
Why?
| | Central Nervous System Stimulants | 5 | 2014 | 185 | 0.340 |
Why?
| | Receptor, Melatonin, MT2 | 1 | 2010 | 3 | 0.320 |
Why?
| | Cross-Over Studies | 8 | 2026 | 601 | 0.320 |
Why?
| | Feeding Behavior | 4 | 2025 | 684 | 0.320 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1217 | 0.310 |
Why?
| | Task Performance and Analysis | 3 | 2021 | 198 | 0.310 |
Why?
| | Seasons | 4 | 2022 | 556 | 0.300 |
Why?
| | Auditory Perception | 1 | 2010 | 114 | 0.300 |
Why?
| | Personnel Staffing and Scheduling | 2 | 2020 | 98 | 0.290 |
Why?
| | Internship and Residency | 4 | 2021 | 1257 | 0.290 |
Why?
| | Memory, Short-Term | 2 | 2009 | 271 | 0.290 |
Why?
| | Exercise | 6 | 2026 | 2201 | 0.280 |
Why?
| | Anxiety | 3 | 2025 | 1109 | 0.270 |
Why?
| | Problem Solving | 1 | 2009 | 156 | 0.270 |
Why?
| | Accidental Falls | 1 | 2011 | 222 | 0.270 |
Why?
| | Hemoglobins | 2 | 2023 | 384 | 0.270 |
Why?
| | Postural Balance | 1 | 2011 | 240 | 0.260 |
Why?
| | Patient Safety | 3 | 2020 | 347 | 0.260 |
Why?
| | Acute-Phase Reaction | 1 | 2007 | 37 | 0.260 |
Why?
| | Bone Density | 3 | 2020 | 482 | 0.260 |
Why?
| | RNA, Ribosomal, 16S | 4 | 2024 | 558 | 0.250 |
Why?
| | Arousal | 4 | 2021 | 157 | 0.250 |
Why?
| | Bone and Bones | 2 | 2020 | 314 | 0.240 |
Why?
| | Healthy Volunteers | 2 | 2018 | 215 | 0.240 |
Why?
| | Cell Adhesion Molecules | 1 | 2007 | 178 | 0.240 |
Why?
| | Athletes | 2 | 2026 | 419 | 0.220 |
Why?
| | Insulin | 5 | 2026 | 2507 | 0.220 |
Why?
| | Fasting | 4 | 2022 | 277 | 0.210 |
Why?
| | Universities | 3 | 2023 | 452 | 0.210 |
Why?
| | Glucans | 1 | 2024 | 22 | 0.210 |
Why?
| | Affect | 2 | 2019 | 318 | 0.210 |
Why?
| | Oligosaccharides | 1 | 2024 | 60 | 0.200 |
Why?
| | Sex Characteristics | 2 | 2025 | 790 | 0.200 |
Why?
| | Bile Acids and Salts | 2 | 2024 | 164 | 0.200 |
Why?
| | Body Weight | 2 | 2025 | 976 | 0.200 |
Why?
| | Blood Glucose | 5 | 2026 | 2327 | 0.200 |
Why?
| | Femur Neck | 2 | 2020 | 62 | 0.190 |
Why?
| | Procollagen | 2 | 2020 | 23 | 0.190 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 2 | 2025 | 103 | 0.190 |
Why?
| | Glucose | 3 | 2022 | 1047 | 0.190 |
Why?
| | Light Signal Transduction | 1 | 2002 | 7 | 0.190 |
Why?
| | Hunger | 1 | 2022 | 57 | 0.190 |
Why?
| | Automobile Driving | 1 | 2004 | 155 | 0.190 |
Why?
| | Cardiovascular Diseases | 2 | 2025 | 2168 | 0.180 |
Why?
| | Metadata | 1 | 2022 | 17 | 0.180 |
Why?
| | Insulins | 1 | 2022 | 38 | 0.180 |
Why?
| | Tandem Mass Spectrometry | 2 | 2022 | 576 | 0.180 |
Why?
| | Electromyography | 2 | 2014 | 415 | 0.180 |
Why?
| | Workload | 2 | 2021 | 170 | 0.180 |
Why?
| | Phenotype | 3 | 2025 | 3162 | 0.170 |
Why?
| | Rats, Sprague-Dawley | 2 | 2024 | 2527 | 0.170 |
Why?
| | Eye | 1 | 2022 | 109 | 0.170 |
Why?
| | Intensive Care Units, Pediatric | 2 | 2021 | 285 | 0.170 |
Why?
| | Cognition Disorders | 2 | 2019 | 538 | 0.170 |
Why?
| | Osteogenesis | 2 | 2020 | 208 | 0.170 |
Why?
| | Anxiety Disorders | 1 | 2024 | 373 | 0.160 |
Why?
| | Feces | 2 | 2024 | 513 | 0.160 |
Why?
| | Contraceptives, Oral | 1 | 2000 | 37 | 0.160 |
Why?
| | Child, Preschool | 11 | 2025 | 11787 | 0.160 |
Why?
| | Middle Aged | 16 | 2026 | 35875 | 0.160 |
Why?
| | Cytokines | 2 | 2011 | 2061 | 0.160 |
Why?
| | Motor Vehicles | 1 | 2020 | 30 | 0.160 |
Why?
| | Postmenopause | 2 | 2019 | 391 | 0.160 |
Why?
| | Mycobacterium | 1 | 2021 | 116 | 0.150 |
Why?
| | Comorbidity | 1 | 2025 | 1658 | 0.150 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2021 | 893 | 0.150 |
Why?
| | Schools | 2 | 2023 | 453 | 0.150 |
Why?
| | Contraceptives, Oral, Hormonal | 1 | 1999 | 30 | 0.150 |
Why?
| | Jet Lag Syndrome | 3 | 2023 | 13 | 0.150 |
Why?
| | Erythrocytes | 2 | 2023 | 757 | 0.150 |
Why?
| | Work Performance | 1 | 2019 | 7 | 0.150 |
Why?
| | C-Reactive Protein | 2 | 2015 | 416 | 0.150 |
Why?
| | Drug Interactions | 1 | 2000 | 398 | 0.150 |
Why?
| | Neuropsychological Tests | 4 | 2010 | 1134 | 0.140 |
Why?
| | RNA, Bacterial | 1 | 2020 | 189 | 0.140 |
Why?
| | Peptide Fragments | 2 | 2020 | 699 | 0.140 |
Why?
| | Child | 9 | 2025 | 22633 | 0.140 |
Why?
| | Menstrual Cycle | 1 | 1999 | 140 | 0.140 |
Why?
| | Adaptation, Physiological | 4 | 2016 | 570 | 0.140 |
Why?
| | Pandemics | 3 | 2023 | 1694 | 0.140 |
Why?
| | Dysbiosis | 2 | 2016 | 187 | 0.140 |
Why?
| | Benzhydryl Compounds | 2 | 2010 | 82 | 0.130 |
Why?
| | Bacteria | 2 | 2024 | 889 | 0.130 |
Why?
| | Osteocalcin | 3 | 2022 | 38 | 0.130 |
Why?
| | Meals | 3 | 2023 | 130 | 0.130 |
Why?
| | Child Behavior | 1 | 2019 | 236 | 0.130 |
Why?
| | Health Promotion | 1 | 2023 | 774 | 0.130 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2019 | 180 | 0.120 |
Why?
| | Parents | 2 | 2023 | 1403 | 0.120 |
Why?
| | Head-Down Tilt | 1 | 2016 | 6 | 0.120 |
Why?
| | Plasma | 1 | 2018 | 225 | 0.120 |
Why?
| | Child Health | 1 | 2018 | 157 | 0.120 |
Why?
| | United States | 5 | 2026 | 15966 | 0.120 |
Why?
| | Risk Factors | 5 | 2020 | 10779 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2015 | 2027 | 0.120 |
Why?
| | Endophenotypes | 1 | 2015 | 21 | 0.120 |
Why?
| | Food Deprivation | 1 | 2015 | 27 | 0.120 |
Why?
| | Immunomodulation | 1 | 2016 | 101 | 0.110 |
Why?
| | Brain | 3 | 2014 | 2933 | 0.110 |
Why?
| | Luminescence | 1 | 2015 | 39 | 0.110 |
Why?
| | Collagen Type I | 3 | 2021 | 147 | 0.110 |
Why?
| | Receptors, Melatonin | 1 | 2015 | 2 | 0.110 |
Why?
| | Metabolic Syndrome | 2 | 2016 | 354 | 0.110 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2021 | 2583 | 0.110 |
Why?
| | Peptide YY | 1 | 2014 | 25 | 0.110 |
Why?
| | Age Factors | 2 | 2014 | 3333 | 0.110 |
Why?
| | Animals | 13 | 2024 | 38058 | 0.110 |
Why?
| | Public Health | 2 | 2018 | 566 | 0.110 |
Why?
| | Metabolome | 3 | 2023 | 384 | 0.110 |
Why?
| | Prehypertension | 1 | 2015 | 27 | 0.110 |
Why?
| | Cyclic AMP | 1 | 2015 | 209 | 0.110 |
Why?
| | Ghrelin | 1 | 2014 | 38 | 0.110 |
Why?
| | Alpha Rhythm | 1 | 2014 | 11 | 0.110 |
Why?
| | Executive Function | 1 | 2019 | 461 | 0.110 |
Why?
| | Astronauts | 1 | 2014 | 30 | 0.110 |
Why?
| | Electrooculography | 1 | 2014 | 12 | 0.110 |
Why?
| | Theta Rhythm | 1 | 2014 | 18 | 0.100 |
Why?
| | Memory | 2 | 2009 | 295 | 0.100 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2019 | 1720 | 0.100 |
Why?
| | Insulin-Secreting Cells | 1 | 2018 | 388 | 0.100 |
Why?
| | Prevalence | 3 | 2017 | 2834 | 0.100 |
Why?
| | Age of Onset | 1 | 2015 | 551 | 0.100 |
Why?
| | Biosensing Techniques | 1 | 2015 | 139 | 0.100 |
Why?
| | Nicotinic Agonists | 1 | 2015 | 136 | 0.100 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 151 | 0.100 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 635 | 0.100 |
Why?
| | Leptin | 1 | 2014 | 245 | 0.100 |
Why?
| | Cannabis | 1 | 2020 | 509 | 0.100 |
Why?
| | Calorimetry | 1 | 2013 | 72 | 0.100 |
Why?
| | Nursing Homes | 1 | 2015 | 172 | 0.090 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 244 | 0.090 |
Why?
| | Brain Mapping | 1 | 1995 | 536 | 0.090 |
Why?
| | Mice | 6 | 2023 | 18339 | 0.090 |
Why?
| | Nicotine | 1 | 2015 | 331 | 0.090 |
Why?
| | Aminolevulinic Acid | 1 | 2011 | 4 | 0.090 |
Why?
| | Langerhans Cells | 1 | 2011 | 12 | 0.090 |
Why?
| | Environment | 2 | 2011 | 305 | 0.090 |
Why?
| | E-Selectin | 2 | 2011 | 61 | 0.090 |
Why?
| | Photochemotherapy | 1 | 2011 | 39 | 0.090 |
Why?
| | Photosensitizing Agents | 1 | 2011 | 42 | 0.080 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2015 | 300 | 0.080 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 1994 | 338 | 0.080 |
Why?
| | Body Mass Index | 5 | 2019 | 2438 | 0.080 |
Why?
| | Cues | 1 | 2013 | 326 | 0.080 |
Why?
| | Pediatric Obesity | 1 | 2018 | 637 | 0.080 |
Why?
| | Pain Measurement | 3 | 2010 | 552 | 0.080 |
Why?
| | Calorimetry, Indirect | 1 | 2010 | 83 | 0.080 |
Why?
| | Electrocardiography | 1 | 2014 | 662 | 0.080 |
Why?
| | Fear | 1 | 2014 | 366 | 0.080 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2010 | 140 | 0.080 |
Why?
| | Adrenal Glands | 1 | 2010 | 77 | 0.080 |
Why?
| | Colorado | 1 | 2020 | 4564 | 0.080 |
Why?
| | Time | 2 | 2020 | 86 | 0.080 |
Why?
| | Aged | 7 | 2020 | 25913 | 0.080 |
Why?
| | Oxygen Consumption | 1 | 2013 | 724 | 0.080 |
Why?
| | Mental Health | 1 | 2016 | 790 | 0.080 |
Why?
| | Occupational Health | 1 | 2012 | 209 | 0.070 |
Why?
| | Neuroprotective Agents | 1 | 2010 | 143 | 0.070 |
Why?
| | Body Temperature Regulation | 2 | 2004 | 108 | 0.070 |
Why?
| | Cross-Sectional Studies | 4 | 2023 | 5868 | 0.070 |
Why?
| | Safety | 1 | 2011 | 356 | 0.070 |
Why?
| | Intensive Care Units | 1 | 2015 | 916 | 0.070 |
Why?
| | Microbiota | 1 | 2016 | 781 | 0.070 |
Why?
| | Stress, Psychological | 2 | 2014 | 1152 | 0.070 |
Why?
| | Endothelium, Vascular | 1 | 2015 | 965 | 0.070 |
Why?
| | Oxidation-Reduction | 2 | 2023 | 1087 | 0.070 |
Why?
| | Amine Oxidase (Copper-Containing) | 1 | 2007 | 5 | 0.070 |
Why?
| | Rats | 3 | 2024 | 5597 | 0.070 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3540 | 0.070 |
Why?
| | Drug Therapy | 1 | 2007 | 80 | 0.060 |
Why?
| | Patient Education as Topic | 1 | 2012 | 780 | 0.060 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2007 | 138 | 0.060 |
Why?
| | Skin | 1 | 2011 | 755 | 0.060 |
Why?
| | Recovery of Function | 1 | 2010 | 707 | 0.060 |
Why?
| | Nipecotic Acids | 1 | 2006 | 6 | 0.060 |
Why?
| | GABA Agonists | 1 | 2006 | 24 | 0.060 |
Why?
| | Glucose Tolerance Test | 2 | 2018 | 361 | 0.060 |
Why?
| | Health Behavior | 1 | 2012 | 785 | 0.060 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2007 | 253 | 0.060 |
Why?
| | Prefrontal Cortex | 1 | 2009 | 328 | 0.060 |
Why?
| | Employment | 1 | 2007 | 188 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 797 | 0.060 |
Why?
| | Glucose Clamp Technique | 1 | 2026 | 199 | 0.060 |
Why?
| | Periodicity | 1 | 2005 | 58 | 0.060 |
Why?
| | Mammals | 1 | 2007 | 293 | 0.060 |
Why?
| | Accelerometry | 1 | 2026 | 119 | 0.060 |
Why?
| | Interleukin-1beta | 1 | 2007 | 395 | 0.060 |
Why?
| | Diet | 2 | 2024 | 1273 | 0.060 |
Why?
| | Psychometrics | 1 | 2009 | 734 | 0.050 |
Why?
| | Police | 1 | 2004 | 45 | 0.050 |
Why?
| | Space Perception | 1 | 2004 | 83 | 0.050 |
Why?
| | Peptides | 2 | 2020 | 995 | 0.050 |
Why?
| | Thrombophilia | 1 | 2024 | 88 | 0.050 |
Why?
| | Factor Analysis, Statistical | 1 | 2004 | 293 | 0.050 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2024 | 58 | 0.050 |
Why?
| | Severity of Illness Index | 3 | 2007 | 2925 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2007 | 780 | 0.050 |
Why?
| | Occupational Diseases | 1 | 2004 | 165 | 0.050 |
Why?
| | Heme | 1 | 2023 | 89 | 0.050 |
Why?
| | Chronic Disease | 1 | 2009 | 1813 | 0.050 |
Why?
| | Travel | 1 | 2023 | 136 | 0.050 |
Why?
| | Infant | 3 | 2023 | 10034 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2024 | 268 | 0.050 |
Why?
| | Nutritional Status | 1 | 2025 | 354 | 0.050 |
Why?
| | Supine Position | 1 | 2002 | 37 | 0.050 |
Why?
| | Computer Simulation | 1 | 2007 | 1025 | 0.050 |
Why?
| | Regression Analysis | 1 | 2025 | 1003 | 0.050 |
Why?
| | Behavior Therapy | 1 | 2025 | 299 | 0.050 |
Why?
| | Rest | 1 | 2022 | 124 | 0.050 |
Why?
| | Carbohydrates | 1 | 2022 | 66 | 0.040 |
Why?
| | Knee | 1 | 2002 | 71 | 0.040 |
Why?
| | Bacteroidetes | 1 | 2021 | 21 | 0.040 |
Why?
| | Temperature | 1 | 2025 | 679 | 0.040 |
Why?
| | Mycobacteriaceae | 1 | 2021 | 35 | 0.040 |
Why?
| | Models, Theoretical | 1 | 2004 | 582 | 0.040 |
Why?
| | Space Flight | 2 | 2014 | 71 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2024 | 441 | 0.040 |
Why?
| | Motor Activity | 2 | 2015 | 721 | 0.040 |
Why?
| | Solar System | 1 | 2019 | 4 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2021 | 454 | 0.040 |
Why?
| | Postprandial Period | 1 | 2020 | 118 | 0.040 |
Why?
| | Immunization | 1 | 2021 | 374 | 0.040 |
Why?
| | Twins | 1 | 2020 | 156 | 0.040 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 2019 | 40 | 0.040 |
Why?
| | Motivation | 1 | 2003 | 610 | 0.040 |
Why?
| | Hot Temperature | 1 | 2021 | 407 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2019 | 276 | 0.030 |
Why?
| | Psychotherapy, Group | 1 | 2018 | 80 | 0.030 |
Why?
| | Phototherapy | 2 | 2007 | 48 | 0.030 |
Why?
| | Hip Joint | 1 | 2019 | 172 | 0.030 |
Why?
| | Health | 1 | 2017 | 81 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 2019 | 405 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 427 | 0.030 |
Why?
| | Depression, Chemical | 1 | 1997 | 16 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 5992 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2024 | 1406 | 0.030 |
Why?
| | Vitamin D | 1 | 2020 | 400 | 0.030 |
Why?
| | Odds Ratio | 1 | 2019 | 1075 | 0.030 |
Why?
| | Health Services Research | 1 | 2019 | 396 | 0.030 |
Why?
| | Weightlessness Simulation | 1 | 2016 | 6 | 0.030 |
Why?
| | Bed Rest | 1 | 2016 | 15 | 0.030 |
Why?
| | Receptors, Transferrin | 1 | 2016 | 28 | 0.030 |
Why?
| | Bilirubin | 1 | 2016 | 97 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2023 | 2947 | 0.030 |
Why?
| | Dietary Carbohydrates | 1 | 2016 | 151 | 0.030 |
Why?
| | Aged, 80 and over | 3 | 2019 | 8265 | 0.030 |
Why?
| | Posture | 1 | 2016 | 196 | 0.030 |
Why?
| | Cohort Studies | 2 | 2019 | 5960 | 0.030 |
Why?
| | Blood Circulation | 1 | 2015 | 44 | 0.030 |
Why?
| | Drinking | 1 | 2015 | 42 | 0.030 |
Why?
| | Bradykinin | 1 | 2015 | 48 | 0.030 |
Why?
| | Nitroprusside | 1 | 2015 | 72 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 2015 | 251 | 0.030 |
Why?
| | Self Report | 1 | 2019 | 872 | 0.030 |
Why?
| | Acclimatization | 1 | 2016 | 172 | 0.030 |
Why?
| | Prostaglandin D2 | 1 | 1994 | 22 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1886 | 0.030 |
Why?
| | Heart | 1 | 2018 | 636 | 0.030 |
Why?
| | Sleep, REM | 1 | 1994 | 44 | 0.030 |
Why?
| | Ibuprofen | 1 | 1994 | 84 | 0.030 |
Why?
| | Health Status | 1 | 2019 | 836 | 0.030 |
Why?
| | Rats, Inbred F344 | 1 | 2014 | 268 | 0.020 |
Why?
| | Intestines | 1 | 2016 | 358 | 0.020 |
Why?
| | Choice Behavior | 1 | 2015 | 177 | 0.020 |
Why?
| | Exercise Test | 1 | 2016 | 634 | 0.020 |
Why?
| | Fibrinolysis | 1 | 2015 | 162 | 0.020 |
Why?
| | Conditioning, Classical | 1 | 2014 | 120 | 0.020 |
Why?
| | Taste | 1 | 2015 | 239 | 0.020 |
Why?
| | Smoking | 1 | 2019 | 1472 | 0.020 |
Why?
| | Buttocks | 1 | 2011 | 14 | 0.020 |
Why?
| | Adiposity | 1 | 2016 | 543 | 0.020 |
Why?
| | Acetaminophen | 1 | 1994 | 264 | 0.020 |
Why?
| | Administration, Topical | 1 | 2011 | 150 | 0.020 |
Why?
| | Twins, Dizygotic | 1 | 2011 | 109 | 0.020 |
Why?
| | Aspirin | 1 | 1994 | 399 | 0.020 |
Why?
| | Twins, Monozygotic | 1 | 2011 | 134 | 0.020 |
Why?
| | Heart Rate | 1 | 2014 | 855 | 0.020 |
Why?
| | Association Learning | 1 | 2009 | 71 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5408 | 0.020 |
Why?
| | Mars | 1 | 2007 | 8 | 0.020 |
Why?
| | Quality of Life | 1 | 2020 | 3185 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2015 | 3121 | 0.020 |
Why?
| | Vitamin B 12 | 1 | 2007 | 127 | 0.020 |
Why?
| | Cell Movement | 1 | 2011 | 965 | 0.020 |
Why?
| | Hypertension | 1 | 2015 | 1263 | 0.010 |
Why?
| | Neutrophils | 1 | 2011 | 1134 | 0.010 |
Why?
| | Phylogeny | 1 | 2009 | 1016 | 0.010 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2006 | 232 | 0.010 |
Why?
| | Inflammation | 1 | 2016 | 2878 | 0.010 |
Why?
| | Headache | 1 | 2005 | 150 | 0.010 |
Why?
| | Antioxidants | 1 | 2007 | 549 | 0.010 |
Why?
| | Hormones | 1 | 2004 | 134 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2014 | 4557 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2011 | 1982 | 0.010 |
Why?
| | Bicycling | 1 | 2004 | 120 | 0.010 |
Why?
| | Physical Fitness | 1 | 2004 | 209 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2010 | 3604 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2007 | 1985 | 0.010 |
Why?
| | Adaptation, Psychological | 1 | 2007 | 717 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2018 | 17066 | 0.010 |
Why?
| | Aging | 1 | 2011 | 1966 | 0.010 |
Why?
| | Models, Biological | 1 | 2007 | 1821 | 0.010 |
Why?
|
|
Wright's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|